Statistiche di base
| CIK | 1568139 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Bio-En Holdings Corp
SEC Filings (Chronological Order)
Questa pagina fornisce un elenco completo e cronologico dei depositi SEC, esclusi i documenti di proprietà che forniamo altrove.
| March 30, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): x Form 10-K ¨ Form 20-F ¨ Form 11-K o Form 10-Q o Form N-SAR ¨ Form N-CSR For Period Ended: December 31 2022 oTransition Report on Form 10-K oTransition Report on Form 20-F oTransition Report on Form 11-K oTransition Report on Form 10-Q oTransition Report on Form N-SAR For the Transition Period Ended: Nothing in this form shall be construed to imply that the Commission has verified any information contained herein. |
|
| November 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| August 29, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 333 |
|
| August 15, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 SEC File Number 333-186629 CUSIP Number NOTIFICATION OF LATE FILING (Check One): ¨ Form 10-K ¨ Form 11-K ¨ Form 20-F x Form 10-Q ¨ Form 10-D ¨ Form N-CEN ¨ Form N-CSR For Period Ended: June 30, 2022 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Report on Form 10-Q For Transition Period Ended: Nothing in this form shall be construed to imply that the Commission has verified any information contained herein. |
|
| May 16, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| March 31, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 333-186 |
|
| November 15, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ⌧ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Numbe |
|
| August 16, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| May 17, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 333-186629 Bio-En H |
|
| April 14, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 333-186629 BIO-EN HOLDING |
|
| March 29, 2021 |
NT 10-K 1 tm211738d3nt10k.htm FORM 12B-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): x Form 10-K oForm 20-F oForm 11-K o Form 10-Q o Form N-SAR oForm N-CSR For Period Ended: December 31 2020 oTransition Report on Form 10-K oTransition Report on Form 20-F oTransition Report on Form 11-K oTransition Report on Form 10-Q o |
|
| November 16, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30 2020 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 333-186629 Bio-E |
|
| August 14, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30 2020 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 333-186629 Bio-En Hol |
|
| June 4, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 333-186629 Bio-En H |
|
| May 14, 2020 |
10-K 1 tm205239d110k.htm FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission fi |
|
| May 12, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 12, 2020 Bio-En Holdings Corp. (Exact Name of Registrant as Specified in its Charter) Delaware 333-186629 990369776 (State of incorporation) (Commission File Number) (IRS Employer |
|
| April 14, 2020 |
Entry into a Material Definitive Agreement 8-K 1 tm2015870-18k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 14, 2020 Bio-En Holdings Corp. (Exact Name of Registrant as Specified in its Charter) Delaware 333-186629 990369776 (State of incorporation) (Co |
|
| March 27, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): March 27, 2020 Bio-En Holdings Corp. (Exact Name of Registrant as Specified in its Charter) Delaware 333-186629 990369776 (State of incorporation) (Commission File Number) (IRS Employ |
|
| November 29, 2019 |
Exhibit 99.1 Bio-En Holdings Corp Announces Binding Term Sheet to Merge with Leo Riders Company, Positioning the First B2B E-scooter Sharing Company for North America Expansion Combined company should expand e-scooter sharing innovation addressing the safety and environmental concerns of city officials, as well as the need for micromobility solutions. NEW YORK, Nov. 26, 2019 /PRNewswire/ - Bio-En |
|
| November 29, 2019 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): November 26, 2019 Bio-En Holdings Corp. (Exact Name of Registrant as Specified in its Charter) Delaware 333-186629 990369776 (State of incorporation) (Commission File Number) (IRS Emp |
|
| November 29, 2019 |
Amendment, by and between Bio-En Holdings Corp. and Leo Riders Company, dated November 26, 2019. Exhibit 10.2 AMENDMENT TO A BINDING TERM SHEET BETWEEN LEO RODERS COMPANY AND BIO EN HOLDINGS CORP BACKGROUND 1. LEO and BIO entered into a Binding Term Sheet dated 26th November 2019, (the “Term Sheet” or "TS"). 2. LEO and BIO now wish to make certain amendments to the Term Sheet. 3. This Amendment amends the Term Sheet and, subject to the amendments described in this Amendment, and compliance wi |
|
| November 29, 2019 |
Term Sheet, by and between Bio-En Holdings Corp. and Leo Riders Company, dated November 26, 2019. EX-10.1 2 tv533862ex10-1.htm EXHIBIT 10.1 Exhibit 10.1 Binding Term Sheet between. Leo Riders Company and Bio-en Holdings Corp This term sheet (the “Term Sheet”) reflects the principles of a transaction between Leo Riders Company, an Israeli company (“Leo”) engaged in the electric scooter-sharing business in Israel, and Bio-en Holdings Corp, a Delaware corporation (“Bio”) is a voluntary filer that |
|
| November 14, 2019 |
BENH / Bio-En Holdings Corp. 10-Q - Quarterly Report - FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 333-186629 Bio- |
|
| October 17, 2019 |
BENH / Bio-En Holdings Corp. 10-Q - Quarterly Report - FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 333-186629 Bio-En Ho |
|
| October 2, 2019 |
Letter from Weinstein & Co., CPA to the Securities and Exchange Commission* Exhibit 16.1 United States Securities and Exchange Commission Office of the Chief Accountant 100 F Street, N.W. Washington, DC 20549-7561 Re: Bio-En Holdings Corp. To Whom It May Concern: We have read the statements under Item 4.01 in the Form 8-K dated September 26, 2019 of Bio-En Holdings Corp. (the “Company”) filed with the Securities and Exchange Commission and we agree with such statements th |
|
| October 2, 2019 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K AMENDMENT NO. 1 CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 26, 2019 (September 22, 2019) Bio-En Holdings Corp. (Exact name of registrant as specified in its charter) Delaware 333-186629 990369776 (State or other juri |
|
| September 26, 2019 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant 8-K 1 tv5300668k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 26, 2019 (September 22, 2019) Bio-En Holdings Corp. (Exact name of registrant as specified in its charter) Delaware 333-186629 990369776 (State |
|
| August 30, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 28, 2019 (August 26, 2019) Bio-En Holdings Corp. (Exact name of registrant as specified in its charter) Delaware 333-186629 990369776 (State or other jurisdiction of incorporat |
|
| August 15, 2019 |
BENH / Bio-En Holdings Corp. NT 10-Q - - NT 10-Q NT 10-Q 1 tv527741nt10q.htm NT 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 SEC File Number 333-186629 CUSIP Number NOTIFICATION OF LATE FILING (Check One): ¨ Form 10-K ¨ Form 11-K ¨ Form 20-F x Form 10-Q ¨ Form 10-D ¨ Form N-CEN ¨ Form N-CSR For Period Ended: June 30, 2019 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Repo |
|
| May 15, 2019 |
BENH / Bio-En Holdings Corp. 10-Q Quarterly Report FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 333-186629 Bio-En H |
|
| March 19, 2019 |
BENH / Bio-En Holdings Corp. 10-K (Annual Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 333-186629 BIO-EN HOLDING |
|
| November 14, 2018 |
BENH / Bio-En Holdings Corp. FORM 10-Q (Quarterly Report) 10-Q 1 tv50627110q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2018 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commis |
|
| August 14, 2018 |
BENH / Bio-En Holdings Corp. 10-Q (Quarterly Report) 10-Q 1 tv49980910q.htm 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2018 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File |
|
| May 14, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2018 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 333-186629 Bio-En H |
|
| April 16, 2018 |
BENH / Bio-En Holdings Corp. FORM 10-K (Annual Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2017 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 333-186629 BIO-EN HOLDING |
|
| March 29, 2018 |
BENH / Bio-En Holdings Corp. NT 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): x Form 10-K o Form 20-F o Form 11-K o Form 10-Q o Form N-SAR o Form N-CSR For Period Ended: December 31 2017 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Report on Form 10-Q ¨ Transition Report on Form N-SAR For the Transition Period Ended: Nothing in this form shall be construed to imply that the Commission has verified any information contained herein. |
|
| March 19, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 16, 2018 Bio-En Holdings Corp. (Exact name of registrant as specified in its charter) Delaware 333-186629 990369776 (State or other jurisdiction of incorporation) (Commission Fi |
|
| March 19, 2018 |
Stock Sale Agreement, dated December 27, 2017 by and among the Company and the Purchasers (3) EX-10.1 2 tv488828ex10-1.htm EXHIBIT 10.1 Exhibit 10.1 STOCK SALE AGREEMENT This STOCK SALE AGREEMENT (“Agreement”) is made effective this 8th day of January, 2018 (“Effective Date”) by and between BIO-EN HOLDINGS CORP., with a place of business at 56 Main Street, Monsey, New York 10952 (“Company”), and the individual/entity with the name and address listed below, or its assignees (“Purchaser”). C |
|
| January 10, 2018 |
Stock Sale Agreement, dated January 8, 2018 by and among the Company and the Purchasers. Exhibit 10.1 STOCK SALE AGREEMENT This STOCK SALE AGREEMENT (?Agreement?) is made effective this 8th day of January, 2018 (?Effective Date?) by and between BIO-EN HOLDINGS CORP., with a place of business at 56 Main Street, Monsey, New York 10952 (?Company?), and the individual/entity with the name and address listed below, or its assignees (?Purchaser?). Company and Purchaser are also individually |
|
| January 10, 2018 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 8, 2018 Bio-En Holdings Corp. (Exact name of registrant as specified in its charter) Delaware 333-186629 990369776 (State or other jurisdiction of incorporation) (Commission F |
|
| November 13, 2017 |
BENH / Bio-En Holdings Corp. FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2017 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 333-186629 Bio- |
|
| August 9, 2017 |
BENH / Bio-En Holdings Corp. FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2017 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 333-186629 Bio-En Ho |
|
| May 15, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2017 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 333-186629 Bio-En H |
|
| March 29, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K 10-K 1 v46251210k.htm FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2016 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file |
|
| November 15, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: October 31, 2018 Estimated average burden hours per response ... 2.50 SEC FILE NUMBER 333-186629 CUSIP NUMBER (Check one): ?Form 10-K ? Form 20-F ? Form 11-K x Form 10-Q ? Form 10-D ? Form N-SAR ? Form N-CSR For Period Ended: September 30, 2016 |
|
| November 15, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2016 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 333-186629 Bio- |
|
| August 11, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2016 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 333-186629 Bio-En Ho |
|
| May 16, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2016 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 333-186629 Bio-En H |
|
| March 30, 2016 |
INDEPENDENT CONTRACTOR AGREEMENT EX-10.3 2 v435433ex10-3.htm EXHIBIT 10.3 Exhibit 10.3 INDEPENDENT CONTRACTOR AGREEMENT This INDEPENDENT CONTRACTOR AGREEMENT ("Agreement"), effective as of May 1, 2015 ("Effective Date"), by and between BIO-EN HOLDINGS CORP., a Delaware corporation, with an office at 56 Main Street, Monsey, New York 10952 ("Company"), and OSSIE WEITZMAN, with an address at 1a Rehov Shikun Asher Raanana 43552 Israe |
|
| March 30, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2015 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 333-186069 BIO-EN HOLDING |
|
| November 9, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2015 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 333-186629 Bio- |
|
| August 14, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2015 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 333-186629 Bio-En Ho |
|
| August 7, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 1, 2015 BIO-EN HOLDINGS CORP. (Exact name of registrant as specified in its charter) Delaware 333-186629 990369776 (State or other jurisdiction of incorporation) (Commission File |
|
| August 7, 2015 |
INDEPENDENT CONTRACTOR AGREEMENT Exhibit 10.1 INDEPENDENT CONTRACTOR AGREEMENT This INDEPENDENT CONTRACTOR AGREEMENT ("Agreement"), effective as of May 1, 2015 ("Effective Date"), by and between BIO-EN HOLDINGS CORP., a Delaware corporation, with an office at 56 Main Street, Monsey, New York 10952 ("Company"), and OSSIE WEITZMAN, with an address at 1a Rehov Shikun Asher Raanana 43552 Israel ("Executive"). WHEREAS, Company desires |
|
| May 15, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2015 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 333-186629 Bio-En H |
|
| April 13, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2014 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 333-186069 BIO-EN HOLDING |
|
| March 31, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: August 31, 2015 Estimated average burden hours per response………………………... 2.50 SEC FILE NUMBER 333-186629 CUSIP NUMBER (Check one): ýForm 10-K o Form 20-F o Form 11-K ¨Form 10-Qo Form 10-D o Form N-SAR o Form N-CSR For Period Ended: December 31, |
|
| November 19, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2014 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 333-186629 Bio- |
|
| November 14, 2014 |
BENH / Bio-En Holdings Corp. NT 10-Q - - FORM NT 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: August 31, 2015 Estimated average burden hours per response………………………... 2.50 SEC FILE NUMBER 333-186629 CUSIP NUMBER (Check one): ¨Form 10-K o Form 20-F o Form 11-K ý Form 10-Qo Form 10-D o Form N-SAR o Form N-CSR For Period Ended: September 30 |
|
| October 22, 2014 |
BENH / Bio-En Holdings Corp. CORRESP - - Bio-En Holdings Corp. 56 Main Street Monsey, New York 10952 (845) 364-7151 October 21, 2014 Roger Schwall Assistant Director U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Bio-En Holdings Corp. Current Report on Form 8-K Filed September 11, 2014 File No. 333-186629 Dear Mr. Schwall: Bio-En Holdings Corp. (“BHC”, the “Company”, |
|
| October 22, 2014 |
BIO-EN CORP (A DEVELOPMENT STAGE COMPANY) EX-99.1 2 v391099ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 BIO-EN CORP (A DEVELOPMENT STAGE COMPANY) CONTENTS PAGE 1 REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM PAGE 2 BALANCE SHEET - MARCH 31, 2014 PAGE 3 STATEMENT OF OPERATIONS FROM JANUARY 6, 2014 (INCEPTION) TO MARCH 31, 2014 PAGE 4 STATEMENT OF STOCKHOLDERS’ DEFICIT FROM JANUARY 6, 2014 (INCEPTION) TO MARCH 31, 2014 PAGE 5 STATEMENT OF |
|
| October 22, 2014 |
Exhibit 99.2 Bio-En Holdings, Corp Unaudited Pro Forma Balance Sheets June 30, 2014 Legal Acquirer Accounting Acquirer Bio-En Holdings, Corp Bio-En Corp Adjustments Consolidated ASSETS CURRENT ASSETS: Cash $ - $ 60 $ - $ 60 Total Current Assets - 60 - 60 Total Assets $ - $ 60 $ - $ 60 LIABILITIES AND STOCKHOLDERS' (DEFICIT) EQUITY CURRENT LIABILITIES: Accounts payable and accrued expenses $ 4,154 |
|
| October 22, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A Amendment No. 1 CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 10, 2014 BIO-EN HOLDINGS CORP. (Exact name of registrant as specified in its charter) Delaware 333-186629 990369776 (State or other jurisdiction of incorpo |
|
| October 10, 2014 |
BENH / Bio-En Holdings Corp. CORRESP - - Bio-En Holdings Corp. 56 Main Street Monsey, New York 10952 October 9, 2014 Roger Schwall Assistant Director U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Bio-En Holdings Corp. Current Report on Form 8-K Filed September 11, 2014 File No. 333-186629 Dear Mr. Schwall: We are in receipt of your letter dated September 25, 2014 to |
|
| September 11, 2014 |
Exhibit 10.2 EXCLUSIVE LICENSE AGREEMENT THIS EXCLUSIVE LICENSE AGREEMENT (hereinafter the “LA”) is made this 23rd day of March, 2014 (hereinafter the “Effective Date”) by and between GeneSyst International, Inc., a Delaware Corporation, with an address at 1737 Georgetown Road, Suite J, Hudson, Ohio 44236-5013 (hereinafter the "LICENSOR") and Bio-En Corp., a Delaware Corporation, with a Registered |
|
| September 11, 2014 |
8-K 1 v3879878k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 10, 2014 BIO-EN HOLDINGS CORP. (Exact name of registrant as specified in its charter) Delaware 333-186629 990369776 (State or other jurisdiction |
|
| September 11, 2014 |
BIO-EN CORP (A DEVELOPMENT STAGE COMPANY) EX-99.1 8 v387987ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 BIO-EN CORP (A DEVELOPMENT STAGE COMPANY) CONTENTS PAGE 1 REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM PAGE 2 BALANCE SHEET - MARCH 31, 2014 PAGE 3 STATEMENT OF OPERATIONS FROM JANUARY 6, 2014 (INCEPTION) TO MARCH 31, 2014 PAGE 4 STATEMENT OF STOCKHOLDERS’ DEFICIT FROM JANUARY 6, 2014 (INCEPTION) TO MARCH 31, 2014 PAGE 5 STATEMENT OF |
|
| September 11, 2014 |
Amended and Restated Bylaws of Bio-En Holdings Corp. (1) Exhibit 3.4 AMENDED BY-LAWS OF BIO-EN HOLDINGS CORP. ARTICLE I OFFICES Section 1.1. Registered Office. The registered office of the Corporation required by the laws of the State of Delaware to be maintained in the State of Delaware shall be the registered office named in the original Articles of Incorporation of the Corporation, or such other office as may be designated from time to time by the Bo |
|
| September 11, 2014 |
EX-3.3 4 v387987ex3-3.htm EXHIBIT 3.3 Exhibit 3.3 State of Delaware Secretary of State Division of Corporations Delivered 01:09 PM 08/05/2014 FILED 01:03 PM 08/05/2014 SRV 141036012 - 5019291 FILE CERTIFICATE OF AMENDMENT OF CERTIFICATE OF INCORPORATION OF BIO-EN HOLDINGS CORP. BIO-EN HOLDINGS CORP., a corporation organized and existing under and by virtue of the General Corporation Law of the Sta |
|
| September 11, 2014 |
EX-10.1 6 v387987ex10-1.htm EXHIBIT 10.1 Exhibit 10.1 Execution Copy CANCELLATION AGREEMENT This CANCELLATION AGREEMENT (this “Agreement”), dated August 20, 2014 (the “Effective Date”), by and between BIO-EN HOLDINGS CORP. (the “Company”), a Delaware corporation, and SERENA B. POTASH, individually (the “Canceling Party”). Company and Cancelling Party are also hereinafter individually and jointly r |
|
| September 11, 2014 |
EX-3.2 3 v387987ex3-2.htm EXHIBIT 3.2 Exhibit 3.2 State of Delaware Secretary of State Division of Corporations Delivered 11:02 AM 04/01/2014 FILED 10:59 AM 04/01/2014 SRV 140411221 - 5019291 FILE CERTIFICATE OF AMENDMENT OF CERTIFICATE OF INCORPORATION OF BIO-EN HOLDINGS CORP. Bio-En Holdings Corp., a corporation organized and existing under and by virtue of the General Corporation Law of the Sta |
|
| September 11, 2014 |
Exhibit 2.1 Execution Copy SHARE EXCHANGE/MERGER AGREEMENT This SHARE EXCHANGE/MERGER AGREEMENT (this “Agreement”), dated as of August 21, 2014 (the “Effective Date”), by and among BIO-EN HOLDINGS CORP. f/k/a Olivia, Inc., a Delaware corporation (“BHC”), SERENA B. POTASH (the “BCH Principal Shareholder”); and BIO-EN CORP., a Delaware corporation (“Bio-En”). Each of BHC, BCH Principal Shareholder, |
|
| August 14, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2014 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 333-186629 Bio-En Ho |
|
| August 14, 2014 | ||
| May 20, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2014 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 333-186629 Bio-En H |
|
| May 16, 2014 |
NT 10-Q 1 v378971nt10q.htm FORM NT 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: August 31, 2015 Estimated average burden hours per response………………………... 2.50 SEC FILE NUMBER 333-186629 CUSIP NUMBER (Check one): ¨ Form 10-K o Form 20-F o Form 11-K ý Form 10-Q o Form 10-D o Form N-SAR o |
|
| April 4, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 24, 2014 Bio-En Holdings Corp. (Exact name of registrant as specified in its charter) Delaware 333-186629 990369776 (State or other jurisdiction of incorporation) (Commission Fi |
|
| April 4, 2014 |
EX-10.1 2 v373904ex10-1.htm EXHIBIT 10.1 Stock Purchase Agreement Dated as of March , 2014 By and Among OLIVIA, INC. AND the principal shareholders of OLIVIA, INC. AND SERENA B. POTASH 1 STOCK PURCHASE AGREEMENT THIS STOCK PURCHASE AGREEMENT, (this “Agreement”) is made this day of March, 2014, by and among Elchanan Menachem Grossbaun and Eliezer Prager (each a “Seller” and, collectively, the “Sell |
|
| February 19, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K 10-K 1 olia10k.htm FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2013 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file num |
|
| October 29, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington DC 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington DC 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2013 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 333-186069 OLIVIA, INC. |
|
| September 24, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington DC 20549 Form 10-Q (Amendment No. 1) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington DC 20549 Form 10-Q (Amendment No. |
|
| September 24, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington DC 20549 Form 10-Q (Amendment No. 1) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington DC 20549 Form 10-Q (Amendment No. |
|
| July 25, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington DC 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington DC 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2013 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 333-186069 OLIVIA, INC. |
|
| May 8, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington DC 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington DC 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2013 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 333-186069 OLIVIA, INC. |
|
| April 16, 2013 |
Olivia Inc. 8605 Santa Monica Blvd #88454 Los Angeles, California 90069 Phone: (213) 947-1011 April 16, 2013 By Edgar Anne Nguyen Parker Branch Chief Securities and Exchange Commission Washington DC, 20549 Re: Olivia Inc. Registration Statement on Form S-1 Filed February 13, 2013 File No. 333-186629 Request for Acceleration Thank you for advising us that the Commission will not further review the |
|
| April 15, 2013 |
As filed with the Securities and Exchange Commission on February 13, 2013 Registration No. |
|
| April 15, 2013 |
Olivia Inc. 8605 Santa Monica Blvd #88454 Los Angeles, California 90069 Phone: (213) 947-1011 April 15, 2013 By Edgar Anne Nguyen Parker Branch Chief Securities and Exchange Commission Washington DC, 20549 Re: Olivia Inc. Registration Statement on Form S-1 Filed February 13, 2013 File No. 333-186629 Olivia Inc., acknowledges receipt of the letter dated April 11, 2013 (the "Staff Letter") from the |
|
| April 5, 2013 |
Olivia Inc. 8605 Santa Monica Blvd #88454 Los Angeles, California 90069 Phone: (213) 947-1011 April 5, 2013 By Edgar Anne Nguyen Parker Branch Chief Securities and Exchange Commission Washington DC, 20549 Re: Olivia Inc. Registration Statement on Form S-1 Filed February 13, 2013 File No. 333-186629 Olivia Inc., acknowledges receipt of the letter dated March 27, 2013 (the "Staff Letter") from the s |
|
| April 5, 2013 |
As filed with the Securities and Exchange Commission on February 13, 2013 Registration No. |
|
| March 20, 2013 |
Olivia Inc. 8605 Santa Monica Blvd #88454 Los Angeles, California 90069 Phone: (213) 947-1011 March 20, 2013 By Edgar Anne Nguyen Parker Branch Chief Securities and Exchange Commission Washington DC, 20549 Re: Olivia Inc. Registration Statement on Form S-1 Filed February 13, 2013 File No. 333-186629 Olivia Inc., acknowledges receipt of the letter dated March 8, 2013 (the "Staff Letter") from the s |
|
| March 20, 2013 |
As filed with the Securities and Exchange Commission on February 13, 2013 Registration No. |
|
| February 13, 2013 |
Registration Statement - FORM S-1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 OLIVIA INC. (Name of Small Business Issuer in its Charter) Delaware 2050 990369776 (State or Other Jurisdiction (Primary Standard Industrial (IRS Employer of Organization) Classification Code) Identification #) 8605 Santa Monica Blvd #88454 Los Angeles, CA 90069- |
|
| February 13, 2013 |
Certificate of Incorporation of Bio-En Holdings Corp. (f/k/a Olivia, Inc.) (2) EX-3.1 2 oliviaex31.htm ARTICLES OF INCORPORATION EXHIBIT 3.1 |
|
| February 13, 2013 |
OLIVIA INV. * * * * * BY-LAWS * * * * * A Delaware Corporation ARTICLE I OFFICES Section 1 The registered office of the Corporation in the State of Delaware shall be located in the City and State designated in the Certificate of Incorporation. Section 2 The corporation may also have offices at such other places both within and without the state of Delaware as the Board of Directors may from time t |
